The supplied product information for Enzalutamide40mg.com identifies Enzamide 40 mg as an enzalutamide product associated with Everest.
This website uses that supplied product information but does not add unverified claims about Everest’s corporate history, manufacturing facilities, regulatory approvals, global operations, or distribution network.
Product and Active Ingredient
Enzamide 40 mg contains the active pharmaceutical ingredient enzalutamide according to the supplied website product information.
Enzalutamide is an androgen receptor signaling inhibitor used in selected prostate cancer treatment settings.
The medicine is prescription-only and treatment should be initiated and monitored by an appropriately qualified healthcare professional.
Understanding the Different Company Roles
Medicine packaging and regulatory documents may identify several different organizations.
These can include:
Manufacturer
The manufacturer is the organization responsible for manufacturing the medicinal product or specified manufacturing activities.
Marketing Authorization Holder
The marketing authorization holder is the entity legally responsible for a particular marketing authorization in a specified jurisdiction.
Distributor
A distributor may handle the commercial distribution of a medicine.
Importer
In some markets, an importer may be responsible for bringing a medicine into the country.
Pharmacy or Supplier
The pharmacy or medicine supplier may dispense or supply the product to the patient.
These roles are not necessarily performed by the same company.
Enzamide and Reference Medicine
Xtandi is a reference product containing enzalutamide.
The European Medicines Agency describes Xtandi as containing enzalutamide and lists specific approved prostate cancer indications.
Generic or other enzalutamide products may be authorized under different regulatory pathways and may have different brand names.
Why Manufacturer Identification Matters
Knowing the organization identified on the medicine packaging can help patients and healthcare professionals:
- Check product documentation
- Review batch information
- Identify the relevant patient leaflet
- Contact the appropriate organization when necessary
- Distinguish one product from another
- Verify information in the applicable market
What Patients Should Check
When receiving Enzamide 40 mg, check that the packaging clearly identifies:
- Enzamide
- Enzalutamide
- 40 mg strength
- Batch or lot information
- Expiry date
- Storage requirements
- Manufacturer or responsible company information
- Any applicable authorization or registration information
If important information is missing or appears inconsistent, ask a pharmacist before taking the medicine.
No Unsupported Corporate Claims
Enzalutamide40mg.com is intended to provide transparent medicine information.
The website should not imply that Everest is:
- The original developer of enzalutamide
- The developer of Xtandi
- The holder of every international authorization
- The exclusive manufacturer of enzalutamide
- The distributor in every country
Such statements require specific supporting documentation and can differ by jurisdiction.
Medical Responsibility
The manufacturer of a medicine does not replace the patient’s healthcare professional.
Questions about whether enzalutamide is appropriate, which dose should be used, how long treatment should continue, or whether another medicine can be taken at the same time should be directed to the treating clinician or pharmacist.